Green Biologics fetches $76 mln
UK-based renewable chemicals firm Green Biologics has raised $42 million in equity funding. Swire Pacific Limited and Sofinnova Partners led the round with participation from return backers Capricorn Venture Partners, Oxford Capital Partners, Morningside Technology Partners and ConvergInce Holdings LLC. Also, Green Biologics has received $34 million in mostly debt funding led by Tennenbaum Capital Partners.
21 January 2015•5 mins read
